Gastroenterology
Volume 138, Issue 7 , Pages 2332-2340 , June 2010

Persistence of Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy

  • Jasmohan S. Bajaj

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin
    • Corresponding Author InformationReprint requests Address requests for reprints to: Jasmohan S. Bajaj, MD, MS, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, 1201 Broad Rock Boulevard, Richmond, Virginia 23249. fax: (804) 675 5816
    • ,
  • Christine M. Schubert

      Affiliations

    • Division of Biostatistics, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • Douglas M. Heuman

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • James B. Wade

      Affiliations

    • Division of Psychology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • Douglas P. Gibson

      Affiliations

    • Division of Psychology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • Allyne Topaz

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • Kia Saeian

      Affiliations

    • Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Muhammad Hafeezullah

      Affiliations

    • Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Debulon E. Bell

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • Richard K. Sterling

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • R. Todd Stravitz

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • Velimir Luketic

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • Melanie B. White

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia
    • ,
  • Arun J. Sanyal

      Affiliations

    • Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia

Received 22 December 2009 ,Accepted 11 February 2010.

References 

  1. Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50:2014–2021
  2. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005;42(Suppl):S45–S53
  3. Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45:549–559
  4. Sotil EU, Gottstein J, Ayala E, et al. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl. 2009;15:184–192
  5. Butterworth RF, Giguere JF, Michaud J, et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol. 1987;6:1–12
  6. Rose C, Jalan R. Is minimal hepatic encephalopathy completely reversible following liver transplantation?. Liver Transpl. 2004;10:84–87
  7. Butterworth RF. Neuronal cell death in hepatic encephalopathy. Metab Brain Dis. 2007;22:309–320
  8. Stewart CA, Malinchoc M, Kim WR, et al. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl. 2007;13:1366–1371
  9. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721
  10. Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768–773
  11. Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008;135:1591–1600
  12. Garavan H, Ross TJ, Stein EA. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A. 1999;96:8301–8306
  13. Bajaj JS, Saeian K, Schubert CM, et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology. 2009;50:1175–1183
  14. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  15. Garcia-Tsao G, Lim JK. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802–1829
  16. Bergeron M, Reader TA, Layrargues GP, et al. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res. 1989;14:853–859
  17. de Waele JP, Audet RM, Leong DK, et al. Portacaval anastomosis induces region-selective alterations of the endogenous opioid system in the rat brain. Hepatology. 1996;24:895–901
  18. Pomier-Layrargues G, Spahr L, Butterworth RF. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet. 1995;345:735
  19. Zieve L, Doizaki WM, Zieve J. Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med. 1974;83:16–28
  20. Kril JJ, Butterworth RF. Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease. Hepatology. 1997;26:837–841
  21. Krieger S, Jauss M, Jansen O, et al. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology. 1996;111:147–155
  22. Mullen KD, Cole M, Foley JM. Neurological deficits in “awake” cirrhotic patients on hepatic encephalopathy treatment: missed metabolic or mental disorder?. Gastroenterology. 1996;111:256–257
  23. Gropman AL, Batshaw ML. Cognitive outcome in urea cycle disorders. Mol Genet Metab. 2004;81(Suppl 1):S58–S62
  24. Giguere JF, Butterworth RF. Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy. Neurochem Res. 1984;9:1309–1321
  25. Derbyshire SW, Vogt BA, Jones AK. Pain and Stroop interference tasks activate separate processing modules in anterior cingulate cortex. Exp Brain Res. 1998;118:52–60
  26. Passingham RE. Attention to action. Philos Trans R Soc Lond B Biol Sci. 1996;351:1473–1479
  27. Cohen JD, Perlstein WM, Braver TS, et al. Temporal dynamics of brain activation during a working memory task. Nature. 1997;386:604–608
  28. Friedman NP, Miyake A, Corley RP, et al. Not all executive functions are related to intelligence. Psychol Sci. 2006;17:172–179
  29. Zafiris O, Kircheis G, Rood HA, et al. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage. 2004;22:541–552
  30. Zhang LJ, Yang G, Yin J, et al. Neural mechanism of cognitive control impairment in patients with hepatic cirrhosis: a functional magnetic resonance imaging study. Acta Radiol. 2007;48:577–587
  31. Shawcross DL, Wright G, Olde Damink SW, et al. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis. 2007;22:125–138
  32. Fan P, Lavoie J, Le NL, et al. Neurochemical and electrophysiological studies on the inhibitory effect of ammonium ions on synaptic transmission in slices of rat hippocampus: evidence for a postsynaptic action. Neuroscience. 1990;37:327–334
  33. Ahboucha S, Layrargues GP, Mamer O, et al. Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy. Ann Neurol. 2005;58:169–170
  34. Butterworth RF, Le O, Lavoie J, et al. Effect of portacaval anastomosis on electrically stimulated release of glutamate from rat hippocampal slices. J Neurochem. 1991;56:1481–1484

 Conflicts of interest The authors disclose the following: Dr Bajaj is a consultant for and receives independent grant support from Salix and Ocera. Dr Sanyal is a consultant for Salix Pharmaceuticals. The remaining authors disclose no conflicts.

 Funding Supported in part by the American College of Gastroenterology Junior Faculty Development Award, and by clinical research center grants MO1-RR00065 and MO1-RR00058, NCRR, and NIH (awarded to J.S.B.).

PII: S0016-5085(10)00206-4

doi: 10.1053/j.gastro.2010.02.015

Gastroenterology
Volume 138, Issue 7 , Pages 2332-2340 , June 2010

Article Tools

* Image Usage & Resolution